These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10831)
1. Suppression of the lytic and bactericidal effects of cell wallinhibitory antibiotics. Lopez R; Ronda-Lain C; Tapia A; Waks SB; Tomasz A Antimicrob Agents Chemother; 1976 Oct; 10(4):697-706. PubMed ID: 10831 [TBL] [Abstract][Full Text] [Related]
2. Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria. Goodell EW; Lopez R; Tomasz A Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3293-7. PubMed ID: 9642 [TBL] [Abstract][Full Text] [Related]
3. Secretion of cell wall polymers into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis. Waks S; Tomasz A Antimicrob Agents Chemother; 1978 Feb; 13(2):293-301. PubMed ID: 25617 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of penicillin: triggering of the pneumococcal autolytic enzyme by inhibitors of cell wall synthesis. Tomasz A; Waks S Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4162-6. PubMed ID: 674 [TBL] [Abstract][Full Text] [Related]
5. Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms. Moreillon P; Markiewicz Z; Nachman S; Tomasz A Antimicrob Agents Chemother; 1990 Jan; 34(1):33-9. PubMed ID: 1691615 [TBL] [Abstract][Full Text] [Related]
6. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. Liu HH; Tomasz A J Infect Dis; 1985 Aug; 152(2):365-72. PubMed ID: 2863313 [TBL] [Abstract][Full Text] [Related]
7. Lytic and bactericidal activity of FCE 22101. Jabes D; Tomasz A J Antimicrob Chemother; 1989 Mar; 23 Suppl C():75-83. PubMed ID: 2659573 [TBL] [Abstract][Full Text] [Related]
8. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics. Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241 [TBL] [Abstract][Full Text] [Related]
9. From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view. Tomasz A Rev Infect Dis; 1979; 1(3):434-67. PubMed ID: 45147 [TBL] [Abstract][Full Text] [Related]
10. Role of the pneumococcal autolysin (murein hydrolase) in the release of progeny bacteriophage and in the bacteriophage-induced lysis of the host cells. Ronda-Lain C; Lopez R; Tapia A; Tomasz A J Virol; 1977 Jan; 21(1):366-74. PubMed ID: 13229 [TBL] [Abstract][Full Text] [Related]
11. The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in beta-lactam resistance. Mascher T; Heintz M; Zähner D; Merai M; Hakenbeck R J Bacteriol; 2006 Mar; 188(5):1959-68. PubMed ID: 16484208 [TBL] [Abstract][Full Text] [Related]
12. Characterization of cell wall polymers secreted into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis. Hakenbeck R; Waks S; Tomasz A Antimicrob Agents Chemother; 1978 Feb; 13(2):302-11. PubMed ID: 25618 [TBL] [Abstract][Full Text] [Related]
13. Role of autolysins in the killing of bacteria by some bactericidal antibiotics. Rogers HJ; Forsberg CW J Bacteriol; 1971 Dec; 108(3):1235-43. PubMed ID: 5003174 [TBL] [Abstract][Full Text] [Related]
14. Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. Moreillon P; Tomasz A J Infect Dis; 1988 Jun; 157(6):1150-7. PubMed ID: 2897398 [TBL] [Abstract][Full Text] [Related]
15. Bacteriolytic effect of teicoplanin. Chmara H; Ripa S; Mignini F; Borowski E J Gen Microbiol; 1991 Apr; 137(4):913-9. PubMed ID: 1830328 [TBL] [Abstract][Full Text] [Related]
16. Hydrogen ion control of autolysin-dependent functions in Bacillus subtilis. Jolliffe LK; Langemeier SO; Doyle RJ Microbios; 1983; 38(153-154):187-94. PubMed ID: 6139741 [TBL] [Abstract][Full Text] [Related]
17. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae. Knudsen JD Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659 [TBL] [Abstract][Full Text] [Related]
18. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Severin A; Severina E; Tomasz A Antimicrob Agents Chemother; 1997 Mar; 41(3):504-10. PubMed ID: 9055983 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Verhaegen J; Verbist L J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae. Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]